Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Early detection of cancer"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Display
Original Articles
Colorectal cancer
Public effect of the 2022 Colorectal Cancer Awareness Campaign delivered through a metaverse platform
Tae-Gyun Lee, Gil-Hyeon Song, Hong-min Ahn, Heung-Kwon Oh, Moonkyoung Byun, Eon Chul Han, Sohyun Kim, Chang Woo Kim, Hye Jin Kim, Samin Hong, Kee-Ho Song, Chan Wook Kim, Yong Beom Cho, on behalf of the Public Relations Committee of the Korean Society of Coloproctology (KSCP)
Ann Coloproctol. 2024;40(2):145-153.   Published online April 28, 2023
DOI: https://doi.org/10.3393/ac.2023.00122.0017
  • 14,123 View
  • 178 Download
  • 5 Web of Science
  • 7 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Purpose
The Korean Society of Coloproctology has been conducting Colorectal Cancer Awareness Campaign, also known as the Gold Ribbon Campaign, every September since 2007. The 2022 campaign was held through a metaverse platform targeting the younger age group under the slogan of raising awareness of early-onset colorectal cancer (CRC). This study aimed to analyze the impact of the 2022 campaign on a metaverse platform.
Methods
Anonymized survey data were collected from participants in the metaverse campaign from September 1 to 15, 2022. The satisfaction score of the participants was evaluated by sex, age group, and previous campaign participation status.
Results
During the campaign, 2,770 people visited the metaverse. Among them, 455 people participated in the survey (response rate, 16.4%). Approximately 95% of the participants reported being satisfied with the information provided by the campaign, understood the necessity of undergoing screening for and prevention of early-onset CRC, and were familiar with the structure of the metaverse. The satisfaction score for campaign information tended to decrease as the participants’ age increased. When the participants’ overall level of satisfaction with the metaverse platform was assessed, teenagers scored particularly lower than the other age groups. The satisfaction scores for CRC information provided in the metaverse, as well as the scores for recognizing the seriousness and necessity of screening for early-onset CRC, indicated a high positive tendency (P<0.001).
Conclusion
Most of the 2022 Gold Ribbon Campaign participants were satisfied with the metaverse platform. Medical society should pay attention to increasing participation in and satisfaction with future public campaigns.

Citations

Citations to this article as recorded by  
  • Metaverse in surgery — origins and future potential
    Enrico Checcucci, Alessandro Veccia, Stefano Puliatti, Pieter De Backer, Pietro Piazza, Karl-Friedrich Kowalewski, Severin Rodler, Mark Taratkin, Ines Rivero Belenchon, Loic Baekelandt, Sabrina De Cillis, Alberto Piana, Ahmed Eissa, Juan Gomez Rivas, Giov
    Nature Reviews Urology.2026; 23(1): 50.     CrossRef
  • CONGA: CONscientization GAme for Colon Cancer Literacy in Last-Semester Software Engineering Students
    Franklin Parrales-Bravo, Jonatan Guillen-Salabarria, Janio Jadán-Guerrero, Leonel Vasquez-Cevallos
    Computers.2026; 15(3): 143.     CrossRef
  • Meeting report on the 8th Asian Science Editors’ Conference and Workshop 2024
    Eun Jung Park
    Science Editing.2025; 12(1): 66.     CrossRef
  • Toward Diagnosis of Diseases Using Emerging Technologies: A Comprehensive Survey of the State of the Art in Metaverse
    Nasim Aslani, Ali Garavand, Riccardo Ortale
    International Journal of Intelligent Systems.2025;[Epub]     CrossRef
  • Global perspectives on young-onset colorectal cancer: epidemiology, challenges, and advances
    Drew Goldberg, Erica Pettke
    Seminars in Colon and Rectal Surgery.2025; 36(3): 101118.     CrossRef
  • #CRCandMe: results of a pre-post quasi-experimental study of a mass media campaign to increase early-onset colorectal cancer awareness in Utah and Wisconsin
    Ami E Sedani
    American Journal of Cancer Research.2024; 14(8): 3873.     CrossRef
  • Metaverso: perspectivas, possibilidades e limitações
    Walter Rodrigues Marques, Maria Neuraildes Gomes Viana, Anderson Boás Viana, Luís Claúdio Azevedo Gomes, Francilene Silva Cruz, Bruna Monique Cunha Rodrigues, Andréa Luísa Frazão Silva, Regeanne Santos Guaianaz, Daiane Leite Chaves Bezerra, Diêgo Jorge Lo
    Caderno Pedagógico.2024; 21(13): e12984.     CrossRef
Special issue, Malignant disease, Rectal cancer,Colorectal cancer,Epidemiology & etiology
Has the COVID-19 Pandemic Caused Upshifting in Colorectal Cancer Stage?
Ji Ha Lim, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Yong Beom Cho, Jung Wook Huh, Yoon Ah Park, Jung Kyong Shin
Ann Coloproctol. 2021;37(4):253-258.   Published online August 9, 2021
DOI: https://doi.org/10.3393/ac.2021.00269.0038
  • 7,004 View
  • 100 Download
  • 22 Web of Science
  • 23 Citations
AbstractAbstract PDF
Purpose
Coronavirus disease 2019 (COVID-19) has affected many parts of daily life and healthcare, including cancer screening and diagnosis. The purpose of this study was to determine whether there was an upshift in the colorectal cancer stage at diagnosis due to delays related to the COVID-19 outbreak.
Methods
From January to June of each year from 2017 to 2020, a total of 3,229 patients who were first diagnosed with colorectal cancer were retrospectively reviewed. Those enrolled from 2017 to 2019 were classified as the ‘pre-COVID’ group, and those enrolled in 2020 were classified as the ‘COVID’ group. The primary outcome was the rate of stage IV disease at the time of diagnosis.
Results
There was no statistically significant difference in the proportion of stage IV patients between the pre-COVID and COVID groups (P=0.19). The median preoperative carcinoembryonic antigen level in the COVID group was higher than in the pre-COVID group in all stages (all P<0.05). In stage I, II patients who underwent radical surgery, the lymphatic invasion was more presented in COVID patients (P=0.009).
Conclusion
We did not find significant stage upshifting in colorectal cancer during the COVID-19 outbreak. However, there were more initially unresectable stage IV colorectal cancer patients with a low conversion rate to resectable status, and more patients had factors related to poor prognosis. These results may become more apparent over time, so it is vital not to neglect cancer screening to not delay the diagnosis during the COVID-19 epidemic.

Citations

Citations to this article as recorded by  
  • The impact of extended invitation intervals on stage distribution of screen‐detected and interval cancer within the Dutch colorectal cancer screening program
    Maria‐Alexandra Katsara, Danica van den Berg, Manon C. W. Spaander, Adriana J. van Vuuren, Evelien Dekker, Folkert J. van Kemenade, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp‐Vogelaar, Esther Toes‐Zoutendijk
    International Journal of Cancer.2025; 157(2): 298.     CrossRef
  • The COVID-19 pandemic and clinical characteristics of colorectal cancer: a multicenter retrospective study
    Yoon Dae Han, Sung Uk Bae, Woo Ram Kim, Dae Ro Lim, Chang Woo Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Impact of the COVID-19 pandemic on the diagnosis, tumor characteristics, and survival outcomes of colorectal cancer: a retrospective cohort study
    Enver Yarikkaya, Merve Cin, Sena Ecin-Demezoglu, Beste Noyan-Mod, Mert Mahsuni Sevinc, Yakup Bozkaya, Nevra Dursun-Kepkep
    Annals of Saudi Medicine.2025; 45(3): 169.     CrossRef
  • Was there any change in surgical treatment for colorectal cancer during the COVID-19 pandemic?
    Yeajin Moon, Seung Hun Lee, Seung Hyun Lee
    Kosin Medical Journal.2025; 40(3): 207.     CrossRef
  • The impact of COVID-19 on patients diagnosed with melanoma, breast, and colorectal cancer
    Danielle Hanuschak, Mallori DePiero, Melissa DeMoraes, Shamoore Bailly, Muni Rubens, Paul Lindeman, Michael Zinner, Geoffrey Young
    The American Journal of Surgery.2024; 229: 36.     CrossRef
  • The global pandemic's second deadly hit: cancer care
    Emma Bradley, Magge Deepa
    The American Journal of Surgery.2024; 229: 34.     CrossRef
  • Trends in the Stage Distribution of Colorectal Cancer During the COVID-19 Pandemic in Japan: A Nationwide Hospital-claims Data Analysis
    Masato Ota, Kohei Taniguchi, Mitsuhiro Asakuma, Sang-Woong Lee, Yuri Ito
    Journal of Epidemiology.2024; 34(7): 356.     CrossRef
  • Inadvertent laparoscopic lavage of perforated colon cancer: a systematic review
    Mahir Gachabayov, Agon Kajmolli, Luis Quintero, Daniel M. Felsenreich, Dorin E. Popa, Dejan Ignjatovic, Roberto Bergamaschi
    Langenbeck's Archives of Surgery.2024;[Epub]     CrossRef
  • Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis
    Simon Marty, Guillaume Lamé, Etienne Guével, Sonia Priou, Gilles Chatellier, Christophe Tournigand, Emmanuelle Kempf
    BMC Cancer.2024;[Epub]     CrossRef
  • Measuring the impact of COVID-19 on cancer survival using an interrupted time series analysis
    Pascal Lambert, Katie Galloway, Allison Feely, Oliver Bucher, Piotr Czaykowski, Pamela Hebbard, Julian O Kim, Marshall Pitz, Harminder Singh, Maclean Thiessen, Kathleen M Decker
    JNCI Cancer Spectrum.2024;[Epub]     CrossRef
  • Decreased Positive Fecal Occult Blood Tests and Delayed Medical Presentation for Colorectal Cancer during the Initial COVID-19 Pandemic Period: A Single-center Experience
    Tadataka Takagi, Fumikazu Koyama, Hiroyuki Kuge, Yosuke Iwasa, Takeshi Takei, Tomomi Sadamitsu, Kosuke Fujimoto, Suzuka Harada, Takashi Tamura, Goki Ejiri, Chihiro Yoshikawa, Masayuki Sho
    Journal of the Anus, Rectum and Colon.2024; 8(3): 188.     CrossRef
  • Impact of COVID-19 Pandemic on the Clinical and Pathologic Characteristics of Colorectal Cancer: A Retrospective Multicenter Study in South Korea
    Jae Hyun Kang, Il Tae Son, Sang Nam Yoon, Jin Soo Ihm, Byung Mo Kang, Jong Kim
    Cancer Management and Research.2024; Volume 16: 1131.     CrossRef
  • The COVID-19 pandemic's impact on prostate cancer screening and diagnosis in Korea
    Byeong Jin Kang, Kyung Hwan Kim, Hong Koo Ha
    Kosin Medical Journal.2023; 38(3): 193.     CrossRef
  • Measuring the impact of the COVID‐19 pandemic on colorectal cancer presentation: a retrospective comparative study
    Kirsten Fullard, Daniel Steffens, Michael Solomon, Joo‐Shik Shin, Cherry Koh
    ANZ Journal of Surgery.2023; 93(12): 2951.     CrossRef
  • Influence of the COVID-19 Pandemic on the Treatment Patterns and Outcomes of Colorectal Cancer
    In Ja Park
    The Ewha Medical Journal.2023;[Epub]     CrossRef
  • Colorectal Surgery in the COVID-19 Era: A Systematic Review and Meta-Analysis
    Nikolaos Pararas, Anastasia Pikouli, Dimitrios Papaconstantinou, Georgios Bagias, Constantinos Nastos, Andreas Pikoulis, Dionysios Dellaportas, Panagis Lykoudis, Emmanouil Pikoulis
    Cancers.2022; 14(5): 1229.     CrossRef
  • Short-Term Impact of Temporary Shutdown of a University-Affiliated Hospital on Patients With Colorectal Cancer During the Coronavirus Disease 2019 Pandemic
    Youn Young Park, Jaeim Lee, Kil-yong Lee, Seong Taek Oh
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Surgical safety in the COVID-19 era: present and future considerations
    Young Il Kim, In Ja Park
    Annals of Surgical Treatment and Research.2022; 102(6): 295.     CrossRef
  • The effect of the COVID-19 pandemic on the outcomes of surgically treated colorectal diseases: a retrospective cohort study
    Gülten Çiçek Okuyan, Melih Yıldırım
    Annals of Surgical Treatment and Research.2022; 103(2): 104.     CrossRef
  • Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic
    Sami Akbulut, Abdirahman Sakulen Hargura, Ibrahim Umar Garzali, Ali Aloun, Cemil Colak
    World Journal of Clinical Cases.2022; 10(26): 9228.     CrossRef
  • Epidemiology, risk factors, and prevention of colorectal cancer
    Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
    Journal of the Korean Medical Association.2022; 65(9): 549.     CrossRef
  • Epidemiology, Risk Factors, and Prevention of Colorectal Cancer-An English Version
    Kyung Uk Jung, Hyung Ook Kim, Hungdai Kim
    Journal of the Anus, Rectum and Colon.2022; 6(4): 231.     CrossRef
  • No evidence of delay in colorectal cancer diagnosis during the COVID-19 pandemic in Gwangju and Jeonnam, Korea
    Hye-Yeon Kim, Min-Gyeong Kim, Mi-Ran Kang, Jeong-Ho Yang, Min-Ho Shin, Sun-Seog Kweon
    Epidemiology and Health.2022; 44: e2022092.     CrossRef
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP